期刊
ONCOTARGET
卷 7, 期 37, 页码 59144-59157出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.10828
关键词
ZFP36; tristetraprolin; colon cancer; b-catenin; epithelial mesenchymal transition
资金
- Fondazione di Vignola, Vignola (Mo), Italy
- British Heart Foundation (BHF) Intermediate Basic Science Fellowship [FS/11/52/29018]
- BHF studentship [FS/14/7/30574]
- British Heart Foundation [FS/14/7/30574, FS/11/52/29018] Funding Source: researchfish
The mRNA-destabilizing protein ZFP36 has been previously described as a tumor suppressor whose expression is lost during colorectal cancer development. In order to evaluate its role in this disease, we restored ZFP36 expression in different cell contexts, showing that the presence of this protein impairs the epithelial-to-mesenchymal transition (EMT) and induces a higher susceptibility to anoikis. Consistently, we found that ZFP36 inhibits the expression of three key transcription factors involved in EMT: ZEB1, MACC1 and SOX9. Finally, we observed for the first time that its expression negatively correlates with the activity of Wnt/beta-catenin pathway, which is constitutively activated in colorectal cancer. This evidence provides a clue on the mechanism leading to the loss of ZFP36 in CRC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据